Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Cullinan Oncology Inc’s current trading price is -16.97% away from its 52-week high, while its distance from the 52-week low is 113.87%. The stock’s price range over this period has fluctuated between $7.64 and $19.68. The company, operating within the financial sector, had a trading volume of approximately 0.47 million for the day, which was noticeably higher than the average daily share volume of 0.41 million over the last 3 months.
Cullinan Oncology Inc saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $19.68 on 02/12/24, while the lowest price for the same duration was marked at $7.64 on 12/12/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Cullinan Oncology Inc (CGEM) has experienced a quarterly rise of 78.00% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 703.76M and boasts a workforce of 85 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 12.51, with a change in price of +7.84. Similarly, Cullinan Oncology Inc recorded 334,763 in trading volume during the last 100 days, posting a change of +92.24%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for CGEM stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.
CGEM Stock Stochastic Average
Today’s raw stochastic average for Cullinan Oncology Inc over the last 50 days is 65.50%.This indicates a increase from the raw stochastic average of the past 20 days, which was 31.19%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 18.58% and 11.09%, respectively.
CGEM Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Until today this year the stock’s price performance recorded an increase of 60.35%. However, over the last six months, the performance has been weaker by 71.46%. The price of CGEM decreased -4.28% over the last 30 days. And in the last five days, it has fallen by -3.37%.
